Genomic instability-based transgenic models of prostate cancer

Area of Science:

• Oncology
• Genetics
• Animal Models

Background:

• Human prostate cancer exhibits a broad spectrum of disease.
• Genomic instability is implicated in prostate cancer induction.
• Developing accurate animal models is crucial for studying cancer progression.

Purpose of the Study:

• To create transgenic mouse models for human prostate cancer.
• To investigate the role of specific genes (ECO:RI, c-fos) in prostate carcinogenesis.
• To establish a model for studying early-stage prostate cancer mechanisms.

Main Methods:

• Targeted prostate-specific expression of ECO:RI and c-fos genes using the probasin promoter (PB) in mice.
• Histological examination of prostate tissues from 4 to 24 months of age.
• Analysis of p53, proliferating cell nuclear antigen (PCNA), and Ki67 expression in PBECO:RI mice.

Main Results:

• PBECO:RI mice developed hyperplasia, prostatic intra-epithelial neoplasia, and adenocarcinoma.
• PBfos mice showed no significant pathology.
• Elevated PCNA and Ki67 levels correlated with prostatic lesion severity in PBECO:RI mice.
• p53 mutations were not detected.

Conclusions:

• The PBECO:RI transgenic mouse model effectively mimics early stages of human prostate cancer.
• This model provides a platform for studying prostate carcinogenesis mechanisms.
• Further research can explore events leading to advanced prostate disease using this model.